annb0t
Top 20
SYDNEY, Sept. 9, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the upcoming 24th Annual Global Investment Conference, held in New York, NY, from 12 â 14 September 2022. Kazia Therapeutics Limited Logo (PRNewsfoto/Kazia Therapeutics Limited)
Dr Garner's presentation will review three positive data read-outs that Kazia has reported so far in 2022 a...
>>> Read more: KAZIA THERAPEUTICS TO PRESENT AT HC WAINWRIGHT 24th ANNUAL GLOBAL INVESTMENT CONFERENCE
Dr Garner's presentation will review three positive data read-outs that Kazia has reported so far in 2022 a...
>>> Read more: KAZIA THERAPEUTICS TO PRESENT AT HC WAINWRIGHT 24th ANNUAL GLOBAL INVESTMENT CONFERENCE
